#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=2.
1-1	0-2	2.	_	_	_	_

#Text=The Mechanism of Action
2-1	3-6	The	abstract[1]	new[1]	_	_
2-2	7-16	Mechanism	abstract[1]	new[1]	_	_
2-3	17-19	of	abstract[1]	new[1]	_	_
2-4	20-26	Action	abstract[1]|person	new[1]|new	_	_

#Text=Only Lucilia sericata larvae from certified farms can be safely used in medicine .
3-1	27-31	Only	plant[5]	new[5]	coref	7-4[0_5]
3-2	32-39	Lucilia	place|plant[5]	new|new[5]	coref	5-10
3-3	40-48	sericata	plant|plant[5]	new|new[5]	coref	5-11
3-4	49-55	larvae	plant[5]	new[5]	_	_
3-5	56-60	from	plant[5]	new[5]	_	_
3-6	61-70	certified	plant[5]|place[6]	new[5]|new[6]	_	_
3-7	71-76	farms	plant[5]|place[6]	new[5]|new[6]	_	_
3-8	77-80	can	_	_	_	_
3-9	81-83	be	_	_	_	_
3-10	84-90	safely	_	_	_	_
3-11	91-95	used	_	_	_	_
3-12	96-98	in	_	_	_	_
3-13	99-107	medicine	abstract	new	_	_
3-14	108-109	.	_	_	_	_

#Text=Complicated procedures of egg disinfection , using chloroamine , povidone-iodine and sodium hypochlorite , are intended to ensure safety during use of this product .
4-1	110-121	Complicated	abstract[8]	new[8]	_	_
4-2	122-132	procedures	abstract[8]	new[8]	_	_
4-3	133-135	of	abstract[8]	new[8]	_	_
4-4	136-139	egg	abstract[8]|object|object[10]	new[8]|new|new[10]	_	_
4-5	140-152	disinfection	abstract[8]|object[10]	new[8]|new[10]	_	_
4-6	153-154	,	abstract[8]	new[8]	_	_
4-7	155-160	using	abstract[8]	new[8]	_	_
4-8	161-172	chloroamine	abstract[8]|substance	new[8]|new	_	_
4-9	173-174	,	abstract[8]	new[8]	_	_
4-10	175-190	povidone-iodine	abstract[8]|substance	new[8]|new	_	_
4-11	191-194	and	abstract[8]	new[8]	_	_
4-12	195-201	sodium	abstract[8]|substance|object[14]	new[8]|new|new[14]	_	_
4-13	202-214	hypochlorite	abstract[8]|object[14]	new[8]|new[14]	_	_
4-14	215-216	,	_	_	_	_
4-15	217-220	are	_	_	_	_
4-16	221-229	intended	_	_	_	_
4-17	230-232	to	_	_	_	_
4-18	233-239	ensure	_	_	_	_
4-19	240-246	safety	abstract	new	_	_
4-20	247-253	during	_	_	_	_
4-21	254-257	use	event[16]	new[16]	_	_
4-22	258-260	of	event[16]	new[16]	_	_
4-23	261-265	this	event[16]|substance[17]	new[16]|new[17]	_	_
4-24	266-273	product	event[16]|substance[17]	new[16]|new[17]	_	_
4-25	274-275	.	_	_	_	_

#Text=MDT is based on three mechanisms , observed when Lucilia sericata are introduced to the wound : the mechanical removal of necrotic tissue , bactericidal and bacteriostatic activity , and promotion of the healing process .
5-1	276-279	MDT	abstract	new	_	_
5-2	280-282	is	_	_	_	_
5-3	283-288	based	_	_	_	_
5-4	289-291	on	_	_	_	_
5-5	292-297	three	abstract[19]	new[19]	_	_
5-6	298-308	mechanisms	abstract[19]	new[19]	_	_
5-7	309-310	,	abstract[19]	new[19]	_	_
5-8	311-319	observed	abstract[19]	new[19]	_	_
5-9	320-324	when	_	_	_	_
5-10	325-332	Lucilia	place	giv	coref	17-20
5-11	333-341	sericata	plant	giv	_	_
5-12	342-345	are	_	_	_	_
5-13	346-356	introduced	_	_	_	_
5-14	357-359	to	_	_	_	_
5-15	360-363	the	abstract[22]	new[22]	coref	6-12[32_22]
5-16	364-369	wound	abstract[22]	new[22]	_	_
5-17	370-371	:	_	_	_	_
5-18	372-375	the	event[23]	new[23]	_	_
5-19	376-386	mechanical	event[23]	new[23]	_	_
5-20	387-394	removal	event[23]	new[23]	_	_
5-21	395-397	of	event[23]	new[23]	_	_
5-22	398-406	necrotic	event[23]|object[24]	new[23]|new[24]	coref	13-9[0_24]
5-23	407-413	tissue	event[23]|object[24]	new[23]|new[24]	_	_
5-24	414-415	,	event[23]	new[23]	_	_
5-25	416-428	bactericidal	event[23]|abstract[25]	new[23]|new[25]	_	_
5-26	429-432	and	event[23]|abstract[25]	new[23]|new[25]	_	_
5-27	433-447	bacteriostatic	event[23]|abstract[25]	new[23]|new[25]	_	_
5-28	448-456	activity	event[23]|abstract[25]	new[23]|new[25]	_	_
5-29	457-458	,	_	_	_	_
5-30	459-462	and	_	_	_	_
5-31	463-472	promotion	event[26]	new[26]	_	_
5-32	473-475	of	event[26]	new[26]	_	_
5-33	476-479	the	event[26]|abstract[28]	new[26]|new[28]	coref	7-6[43_28]
5-34	480-487	healing	event[26]|object|abstract[28]	new[26]|new|new[28]	coref	12-10[73_0]
5-35	488-495	process	event[26]|abstract[28]	new[26]|new[28]	_	_
5-36	496-497	.	_	_	_	_

#Text=Reports from the last decade point out that physical contact with the wound is a less important effect of the larval presence within the wound , and is probably a negative effect for the patient , who may feel a physical presence and wiggling in the wound .
6-1	498-505	Reports	abstract[29]	new[29]	_	_
6-2	506-510	from	abstract[29]	new[29]	_	_
6-3	511-514	the	abstract[29]|time[30]	new[29]|new[30]	_	_
6-4	515-519	last	abstract[29]|time[30]	new[29]|new[30]	_	_
6-5	520-526	decade	abstract[29]|time[30]	new[29]|new[30]	_	_
6-6	527-532	point	_	_	_	_
6-7	533-536	out	_	_	_	_
6-8	537-541	that	_	_	_	_
6-9	542-550	physical	abstract[31]	new[31]	coref	6-15[33_31]
6-10	551-558	contact	abstract[31]	new[31]	_	_
6-11	559-563	with	abstract[31]	new[31]	_	_
6-12	564-567	the	abstract[31]|abstract[32]	new[31]|giv[32]	coref	6-24[36_32]
6-13	568-573	wound	abstract[31]|abstract[32]	new[31]|giv[32]	_	_
6-14	574-576	is	_	_	_	_
6-15	577-578	a	abstract[33]|abstract[34]	giv[33]|giv[34]	coref	6-15[34_33]
6-16	579-583	less	abstract[33]|abstract[34]	giv[33]|giv[34]	_	_
6-17	584-593	important	abstract[33]|abstract[34]	giv[33]|giv[34]	_	_
6-18	594-600	effect	abstract[33]|abstract[34]	giv[33]|giv[34]	_	_
6-19	601-603	of	abstract[33]|abstract[34]	giv[33]|giv[34]	_	_
6-20	604-607	the	abstract[33]|abstract[34]|abstract[35]	giv[33]|giv[34]|new[35]	coref	6-40[39_35]
6-21	608-614	larval	abstract[33]|abstract[34]|abstract[35]	giv[33]|giv[34]|new[35]	_	_
6-22	615-623	presence	abstract[33]|abstract[34]|abstract[35]	giv[33]|giv[34]|new[35]	_	_
6-23	624-630	within	abstract[33]|abstract[34]|abstract[35]	giv[33]|giv[34]|new[35]	_	_
6-24	631-634	the	abstract[33]|abstract[34]|abstract[35]|abstract[36]	giv[33]|giv[34]|new[35]|giv[36]	coref	6-46[40_36]
6-25	635-640	wound	abstract[33]|abstract[34]|abstract[35]|abstract[36]	giv[33]|giv[34]|new[35]|giv[36]	_	_
6-26	641-642	,	abstract[34]	giv[34]	_	_
6-27	643-646	and	abstract[34]	giv[34]	_	_
6-28	647-649	is	abstract[34]	giv[34]	_	_
6-29	650-658	probably	abstract[34]|abstract[37]	giv[34]|new[37]	coref	9-2[49_37]
6-30	659-660	a	abstract[34]|abstract[37]	giv[34]|new[37]	_	_
6-31	661-669	negative	abstract[34]|abstract[37]	giv[34]|new[37]	_	_
6-32	670-676	effect	abstract[34]|abstract[37]	giv[34]|new[37]	_	_
6-33	677-680	for	abstract[34]|abstract[37]	giv[34]|new[37]	_	_
6-34	681-684	the	abstract[34]|abstract[37]|person[38]	giv[34]|new[37]|new[38]	_	_
6-35	685-692	patient	abstract[34]|abstract[37]|person[38]	giv[34]|new[37]|new[38]	_	_
6-36	693-694	,	abstract[34]|abstract[37]|person[38]	giv[34]|new[37]|new[38]	_	_
6-37	695-698	who	abstract[34]|abstract[37]|person[38]	giv[34]|new[37]|new[38]	_	_
6-38	699-702	may	abstract[34]|abstract[37]|person[38]	giv[34]|new[37]|new[38]	_	_
6-39	703-707	feel	abstract[34]|abstract[37]|person[38]	giv[34]|new[37]|new[38]	_	_
6-40	708-709	a	abstract[34]|abstract[37]|person[38]|abstract[39]	giv[34]|new[37]|new[38]|giv[39]	_	_
6-41	710-718	physical	abstract[34]|abstract[37]|person[38]|abstract[39]	giv[34]|new[37]|new[38]|giv[39]	_	_
6-42	719-727	presence	abstract[34]|abstract[37]|person[38]|abstract[39]	giv[34]|new[37]|new[38]|giv[39]	_	_
6-43	728-731	and	abstract[34]|abstract[37]|person[38]	giv[34]|new[37]|new[38]	_	_
6-44	732-740	wiggling	abstract[34]|abstract[37]|person[38]	giv[34]|new[37]|new[38]	_	_
6-45	741-743	in	_	_	_	_
6-46	744-747	the	abstract[40]	giv[40]	coref	7-15[0_40]
6-47	748-753	wound	abstract[40]	giv[40]	_	_
6-48	754-755	.	_	_	_	_

#Text=Chemicals secreted by larvae initiate the process of bacterial elimination and remodeling of the wound bed .
7-1	756-765	Chemicals	substance[41]	new[41]	_	_
7-2	766-774	secreted	substance[41]	new[41]	_	_
7-3	775-777	by	substance[41]	new[41]	_	_
7-4	778-784	larvae	substance[41]|plant	new[41]|giv	coref	10-5[55_0]
7-5	785-793	initiate	_	_	_	_
7-6	794-797	the	abstract[43]	giv[43]	coref	12-8[74_43]
7-7	798-805	process	abstract[43]	giv[43]	_	_
7-8	806-808	of	abstract[43]	giv[43]	_	_
7-9	809-818	bacterial	abstract[43]|event[44]	giv[43]|new[44]	_	_
7-10	819-830	elimination	abstract[43]|event[44]	giv[43]|new[44]	_	_
7-11	831-834	and	abstract[43]	giv[43]	_	_
7-12	835-845	remodeling	abstract[43]|abstract[45]	giv[43]|new[45]	_	_
7-13	846-848	of	abstract[43]|abstract[45]	giv[43]|new[45]	_	_
7-14	849-852	the	abstract[43]|abstract[45]|place[47]	giv[43]|new[45]|new[47]	coref	14-5[88_47]
7-15	853-858	wound	abstract[43]|abstract[45]|abstract|place[47]	giv[43]|new[45]|giv|new[47]	coref	9-7[52_0]
7-16	859-862	bed	abstract[43]|abstract[45]|place[47]	giv[43]|new[45]|new[47]	_	_
7-17	863-864	.	_	_	_	_

#Text=Figure 1
8-1	865-871	Figure	abstract[48]	new[48]	_	_
8-2	872-873	1	abstract[48]	new[48]	_	_

#Text=shows the effect of debridement on a necrotic forearm wound measuring over 200 cm² .
9-1	874-879	shows	_	_	_	_
9-2	880-883	the	abstract[49]	giv[49]	_	_
9-3	884-890	effect	abstract[49]	giv[49]	_	_
9-4	891-893	of	abstract[49]	giv[49]	_	_
9-5	894-905	debridement	abstract[49]|event	giv[49]|new	coref	18-14
9-6	906-908	on	abstract[49]	giv[49]	_	_
9-7	909-910	a	abstract[49]|abstract[52]	giv[49]|giv[52]	coref	10-15[58_52]
9-8	911-919	necrotic	abstract[49]|abstract[52]	giv[49]|giv[52]	_	_
9-9	920-927	forearm	abstract[49]|object|abstract[52]	giv[49]|new|giv[52]	coref	10-21
9-10	928-933	wound	abstract[49]|abstract[52]	giv[49]|giv[52]	_	_
9-11	934-943	measuring	abstract[49]|abstract[52]	giv[49]|giv[52]	_	_
9-12	944-948	over	abstract[49]|abstract[52]|abstract[53]	giv[49]|giv[52]|new[53]	_	_
9-13	949-952	200	abstract[49]|abstract[52]|abstract[53]	giv[49]|giv[52]|new[53]	_	_
9-14	953-956	cm²	abstract[49]|abstract[52]|abstract[53]	giv[49]|giv[52]|new[53]	_	_
9-15	957-958	.	_	_	_	_

#Text=Within 72 hours , 100 free-range larvae cleansed over 70 % of necrosis in the wound , revealing the damaged forearm bones .
10-1	959-965	Within	_	_	_	_
10-2	966-968	72	time[54]	new[54]	_	_
10-3	969-974	hours	time[54]	new[54]	_	_
10-4	975-976	,	_	_	_	_
10-5	977-980	100	plant[55]	giv[55]	coref	17-17[106_55]
10-6	981-991	free-range	plant[55]	giv[55]	_	_
10-7	992-998	larvae	plant[55]	giv[55]	_	_
10-8	999-1007	cleansed	_	_	_	_
10-9	1008-1012	over	abstract[56]	new[56]	_	_
10-10	1013-1015	70	abstract[56]	new[56]	_	_
10-11	1016-1017	%	abstract[56]	new[56]	_	_
10-12	1018-1020	of	abstract[56]	new[56]	_	_
10-13	1021-1029	necrosis	abstract[56]|abstract[57]	new[56]|new[57]	coref	11-24[0_57]
10-14	1030-1032	in	abstract[56]|abstract[57]	new[56]|new[57]	_	_
10-15	1033-1036	the	abstract[56]|abstract[57]|abstract[58]	new[56]|new[57]|giv[58]	coref	12-10[0_58]
10-16	1037-1042	wound	abstract[56]|abstract[57]|abstract[58]	new[56]|new[57]|giv[58]	_	_
10-17	1043-1044	,	_	_	_	_
10-18	1045-1054	revealing	_	_	_	_
10-19	1055-1058	the	object[60]	new[60]	_	_
10-20	1059-1066	damaged	object[60]	new[60]	_	_
10-21	1067-1074	forearm	object|object[60]	giv|new[60]	_	_
10-22	1075-1080	bones	object[60]	new[60]	_	_
10-23	1081-1082	.	_	_	_	_

#Text=The above observations suggest the potential use of this method in cases where wounds cover full skin-thickness , with a high risk of necrosis , or an already existing infection .
11-1	1083-1086	The	abstract[61]	new[61]	_	_
11-2	1087-1092	above	abstract[61]	new[61]	_	_
11-3	1093-1105	observations	abstract[61]	new[61]	_	_
11-4	1106-1113	suggest	_	_	_	_
11-5	1114-1117	the	event[62]	new[62]	_	_
11-6	1118-1127	potential	event[62]	new[62]	_	_
11-7	1128-1131	use	event[62]	new[62]	_	_
11-8	1132-1134	of	event[62]	new[62]	_	_
11-9	1135-1139	this	event[62]|abstract[63]	new[62]|new[63]	coref	12-4[71_63]
11-10	1140-1146	method	event[62]|abstract[63]	new[62]|new[63]	_	_
11-11	1147-1149	in	_	_	_	_
11-12	1150-1155	cases	event[64]	new[64]	_	_
11-13	1156-1161	where	event[64]	new[64]	_	_
11-14	1162-1168	wounds	event[64]|object	new[64]|new	_	_
11-15	1169-1174	cover	event[64]	new[64]	_	_
11-16	1175-1179	full	event[64]|object[66]	new[64]|new[66]	_	_
11-17	1180-1194	skin-thickness	event[64]|object[66]	new[64]|new[66]	_	_
11-18	1195-1196	,	event[64]	new[64]	_	_
11-19	1197-1201	with	event[64]	new[64]	_	_
11-20	1202-1203	a	event[64]|abstract[67]	new[64]|new[67]	_	_
11-21	1204-1208	high	event[64]|abstract[67]	new[64]|new[67]	_	_
11-22	1209-1213	risk	event[64]|abstract[67]	new[64]|new[67]	_	_
11-23	1214-1216	of	event[64]|abstract[67]	new[64]|new[67]	_	_
11-24	1217-1225	necrosis	event[64]|abstract[67]|abstract	new[64]|new[67]|giv	coref	21-4
11-25	1226-1227	,	event[64]	new[64]	_	_
11-26	1228-1230	or	event[64]	new[64]	_	_
11-27	1231-1233	an	event[64]|event[69]	new[64]|new[69]	_	_
11-28	1234-1241	already	event[64]|event[69]	new[64]|new[69]	_	_
11-29	1242-1250	existing	event[64]|event[69]	new[64]|new[69]	_	_
11-30	1251-1260	infection	event[64]|event[69]	new[64]|new[69]	_	_
11-31	1261-1262	.	_	_	_	_

#Text=The selection of an appropriate method for the further wound healing process is the next stage of local action .
12-1	1263-1266	The	abstract[70]	new[70]	coref	12-14[75_70]
12-2	1267-1276	selection	abstract[70]	new[70]	_	_
12-3	1277-1279	of	abstract[70]	new[70]	_	_
12-4	1280-1282	an	abstract[70]|abstract[71]	new[70]|giv[71]	_	_
12-5	1283-1294	appropriate	abstract[70]|abstract[71]	new[70]|giv[71]	_	_
12-6	1295-1301	method	abstract[70]|abstract[71]	new[70]|giv[71]	_	_
12-7	1302-1305	for	abstract[70]|abstract[71]	new[70]|giv[71]	_	_
12-8	1306-1309	the	abstract[70]|abstract[71]|abstract[74]	new[70]|giv[71]|giv[74]	coref	18-13[113_74]
12-9	1310-1317	further	abstract[70]|abstract[71]|abstract[74]	new[70]|giv[71]|giv[74]	_	_
12-10	1318-1323	wound	abstract[70]|abstract[71]|abstract|object[73]|abstract[74]	new[70]|giv[71]|giv|giv[73]|giv[74]	coref|coref	14-6|22-18[0_73]
12-11	1324-1331	healing	abstract[70]|abstract[71]|object[73]|abstract[74]	new[70]|giv[71]|giv[73]|giv[74]	_	_
12-12	1332-1339	process	abstract[70]|abstract[71]|abstract[74]	new[70]|giv[71]|giv[74]	_	_
12-13	1340-1342	is	_	_	_	_
12-14	1343-1346	the	abstract[75]	giv[75]	_	_
12-15	1347-1351	next	abstract[75]	giv[75]	_	_
12-16	1352-1357	stage	abstract[75]	giv[75]	_	_
12-17	1358-1360	of	abstract[75]	giv[75]	_	_
12-18	1361-1366	local	abstract[75]|event[76]	giv[75]|new[76]	_	_
12-19	1367-1373	action	abstract[75]|event[76]	giv[75]|new[76]	_	_
12-20	1374-1375	.	_	_	_	_

#Text=A maggot does not literally consume pieces of tissue , but it secretes and excretes digestive enzymes ( digestive secretions and excretions of arginase ) .
13-1	1376-1377	A	animal[77]	new[77]	ana	13-12[0_77]
13-2	1378-1384	maggot	animal[77]	new[77]	_	_
13-3	1385-1389	does	_	_	_	_
13-4	1390-1393	not	_	_	_	_
13-5	1394-1403	literally	_	_	_	_
13-6	1404-1411	consume	_	_	_	_
13-7	1412-1418	pieces	object[78]	new[78]	_	_
13-8	1419-1421	of	object[78]	new[78]	_	_
13-9	1422-1428	tissue	object[78]|object	new[78]|giv	coref	15-1[91_0]
13-10	1429-1430	,	_	_	_	_
13-11	1431-1434	but	_	_	_	_
13-12	1435-1437	it	animal	giv	coref	14-11[89_0]
13-13	1438-1446	secretes	_	_	_	_
13-14	1447-1450	and	_	_	_	_
13-15	1451-1459	excretes	_	_	_	_
13-16	1460-1469	digestive	abstract[81]	new[81]	appos	13-19[82_81]
13-17	1470-1477	enzymes	abstract[81]	new[81]	_	_
13-18	1478-1479	(	_	_	_	_
13-19	1480-1489	digestive	abstract[82]|abstract[83]	giv[82]|giv[83]	appos|appos	13-19[83_82]|13-22[84_83]
13-20	1490-1500	secretions	abstract[82]|abstract[83]	giv[82]|giv[83]	_	_
13-21	1501-1504	and	abstract[83]	giv[83]	_	_
13-22	1505-1515	excretions	abstract[83]|abstract[84]	giv[83]|giv[84]	coref	17-13[105_84]
13-23	1516-1518	of	abstract[83]|abstract[84]	giv[83]|giv[84]	_	_
13-24	1519-1527	arginase	abstract[83]|abstract[84]|abstract	giv[83]|giv[84]|new	coref	18-10
13-25	1528-1529	)	_	_	_	_
13-26	1530-1531	.	_	_	_	_

#Text=Digestion begins directly in the wound bed , outside the maggot ’s body .
14-1	1532-1541	Digestion	event	new	coref	27-1[184_0]
14-2	1542-1548	begins	_	_	_	_
14-3	1549-1557	directly	_	_	_	_
14-4	1558-1560	in	_	_	_	_
14-5	1561-1564	the	place[88]	giv[88]	coref	23-23[149_88]
14-6	1565-1570	wound	abstract|place[88]	giv|giv[88]	coref	16-19[99_0]
14-7	1571-1574	bed	place[88]	giv[88]	_	_
14-8	1575-1576	,	_	_	_	_
14-9	1577-1584	outside	_	_	_	_
14-10	1585-1588	the	object[90]	new[90]	_	_
14-11	1589-1595	maggot	animal[89]|object[90]	giv[89]|new[90]	coref	15-11[92_89]
14-12	1596-1598	’s	animal[89]|object[90]	giv[89]|new[90]	_	_
14-13	1599-1603	body	object[90]	new[90]	_	_
14-14	1604-1605	.	_	_	_	_

#Text=Dead tissue is liquefied and can be easily absorbed by the maggot .
15-1	1606-1610	Dead	object[91]	giv[91]	coref	18-7[0_91]
15-2	1611-1617	tissue	object[91]	giv[91]	_	_
15-3	1618-1620	is	_	_	_	_
15-4	1621-1630	liquefied	_	_	_	_
15-5	1631-1634	and	_	_	_	_
15-6	1635-1638	can	_	_	_	_
15-7	1639-1641	be	_	_	_	_
15-8	1642-1648	easily	_	_	_	_
15-9	1649-1657	absorbed	_	_	_	_
15-10	1658-1660	by	_	_	_	_
15-11	1661-1664	the	animal[92]	giv[92]	_	_
15-12	1665-1671	maggot	animal[92]	giv[92]	_	_
15-13	1672-1673	.	_	_	_	_

#Text=This phenomenon can be easily observed during therapy because of the increase in the amount of exudate from the wound and its specific odor .
16-1	1674-1678	This	abstract[93]	new[93]	_	_
16-2	1679-1689	phenomenon	abstract[93]	new[93]	_	_
16-3	1690-1693	can	_	_	_	_
16-4	1694-1696	be	_	_	_	_
16-5	1697-1703	easily	_	_	_	_
16-6	1704-1712	observed	_	_	_	_
16-7	1713-1719	during	_	_	_	_
16-8	1720-1727	therapy	event	new	coref	36-4[258_0]
16-9	1728-1735	because	_	_	_	_
16-10	1736-1738	of	_	_	_	_
16-11	1739-1742	the	event[95]	new[95]	_	_
16-12	1743-1751	increase	event[95]	new[95]	_	_
16-13	1752-1754	in	event[95]	new[95]	_	_
16-14	1755-1758	the	event[95]|substance[96]	new[95]|new[96]	ana	16-22[0_96]
16-15	1759-1765	amount	event[95]|substance[96]	new[95]|new[96]	_	_
16-16	1766-1768	of	event[95]|substance[96]	new[95]|new[96]	_	_
16-17	1769-1776	exudate	event[95]|substance[96]|substance[97]|substance[98]	new[95]|new[96]|new[97]|new[98]	coref|coref	36-19[0_97]|36-19[262_98]
16-18	1777-1781	from	event[95]|substance[96]|substance[97]|substance[98]	new[95]|new[96]|new[97]|new[98]	_	_
16-19	1782-1785	the	event[95]|substance[96]|substance[97]|substance[98]|abstract[99]	new[95]|new[96]|new[97]|new[98]|giv[99]	coref	20-7[122_99]
16-20	1786-1791	wound	event[95]|substance[96]|substance[97]|substance[98]|abstract[99]	new[95]|new[96]|new[97]|new[98]|giv[99]	_	_
16-21	1792-1795	and	event[95]|substance[96]|substance[98]	new[95]|new[96]|new[98]	_	_
16-22	1796-1799	its	event[95]|substance[96]|substance[98]|substance|abstract[101]	new[95]|new[96]|new[98]|giv|new[101]	_	_
16-23	1800-1808	specific	event[95]|substance[96]|substance[98]|abstract[101]	new[95]|new[96]|new[98]|new[101]	_	_
16-24	1809-1813	odor	event[95]|substance[96]|substance[98]|abstract[101]	new[95]|new[96]|new[98]|new[101]	_	_
16-25	1814-1815	.	_	_	_	_

#Text=Hobson was the first scientist to systematically present the proteolytic effects of digestive enzymes produced by the larvae of Lucilia sericata .
17-1	1816-1822	Hobson	person	new	coref	17-3[103_0]
17-2	1823-1826	was	_	_	_	_
17-3	1827-1830	the	person[103]	giv[103]	_	_
17-4	1831-1836	first	person[103]	giv[103]	_	_
17-5	1837-1846	scientist	person[103]	giv[103]	_	_
17-6	1847-1849	to	person[103]	giv[103]	_	_
17-7	1850-1864	systematically	person[103]	giv[103]	_	_
17-8	1865-1872	present	person[103]	giv[103]	_	_
17-9	1873-1876	the	person[103]|abstract[104]	giv[103]|new[104]	_	_
17-10	1877-1888	proteolytic	person[103]|abstract[104]	giv[103]|new[104]	_	_
17-11	1889-1896	effects	person[103]|abstract[104]	giv[103]|new[104]	_	_
17-12	1897-1899	of	person[103]|abstract[104]	giv[103]|new[104]	_	_
17-13	1900-1909	digestive	person[103]|abstract[104]|abstract[105]	giv[103]|new[104]|giv[105]	coref	19-1[114_105]
17-14	1910-1917	enzymes	person[103]|abstract[104]|abstract[105]	giv[103]|new[104]|giv[105]	_	_
17-15	1918-1926	produced	person[103]|abstract[104]|abstract[105]	giv[103]|new[104]|giv[105]	_	_
17-16	1927-1929	by	person[103]|abstract[104]|abstract[105]	giv[103]|new[104]|giv[105]	_	_
17-17	1930-1933	the	person[103]|abstract[104]|abstract[105]|plant[106]	giv[103]|new[104]|giv[105]|giv[106]	coref	25-23[173_106]
17-18	1934-1940	larvae	person[103]|abstract[104]|abstract[105]|plant[106]	giv[103]|new[104]|giv[105]|giv[106]	_	_
17-19	1941-1943	of	person[103]|abstract[104]|abstract[105]|plant[106]	giv[103]|new[104]|giv[105]|giv[106]	_	_
17-20	1944-1951	Lucilia	person[103]|abstract[104]|abstract[105]|plant[106]|place	giv[103]|new[104]|giv[105]|giv[106]|giv	coref	29-12
17-21	1952-1960	sericata	person[103]|abstract[104]|abstract[105]|plant[106]	giv[103]|new[104]|giv[105]|giv[106]	_	_
17-22	1961-1962	.	_	_	_	_

#Text=The movements of maggots , scratching tissue and secreting arginase , facilitate the debridement process .
18-1	1963-1966	The	event[108]	new[108]	_	_
18-2	1967-1976	movements	event[108]	new[108]	_	_
18-3	1977-1979	of	event[108]	new[108]	_	_
18-4	1980-1987	maggots	event[108]|animal[109]	new[108]|new[109]	coref	20-28[127_109]
18-5	1988-1989	,	event[108]|animal[109]	new[108]|new[109]	_	_
18-6	1990-2000	scratching	event[108]|animal[109]	new[108]|new[109]	_	_
18-7	2001-2007	tissue	event[108]|animal[109]|object	new[108]|new[109]|giv	coref	20-13[124_0]
18-8	2008-2011	and	event[108]|animal[109]	new[108]|new[109]	_	_
18-9	2012-2021	secreting	event[108]|animal[109]	new[108]|new[109]	_	_
18-10	2022-2030	arginase	event[108]|animal[109]|abstract	new[108]|new[109]|giv	_	_
18-11	2031-2032	,	_	_	_	_
18-12	2033-2043	facilitate	_	_	_	_
18-13	2044-2047	the	abstract[113]	giv[113]	coref	21-11[133_113]
18-14	2048-2059	debridement	event|abstract[113]	giv|giv[113]	coref	31-2
18-15	2060-2067	process	abstract[113]	giv[113]	_	_
18-16	2068-2069	.	_	_	_	_

#Text=Other enzymes released include leucine aminopeptidase , collagenase and chymotrypsin-like proteases .
19-1	2070-2075	Other	abstract[114]	giv[114]	coref	20-1[120_114]
19-2	2076-2083	enzymes	abstract[114]	giv[114]	_	_
19-3	2084-2092	released	abstract[114]	giv[114]	_	_
19-4	2093-2100	include	_	_	_	_
19-5	2101-2108	leucine	substance|place[116]	new|new[116]	_	_
19-6	2109-2123	aminopeptidase	place[116]	new[116]	_	_
19-7	2124-2125	,	_	_	_	_
19-8	2126-2137	collagenase	substance	new	coref	25-1
19-9	2138-2141	and	_	_	_	_
19-10	2142-2159	chymotrypsin-like	abstract|abstract[119]	new|new[119]	_	_
19-11	2160-2169	proteases	abstract[119]	new[119]	_	_
19-12	2170-2171	.	_	_	_	_

#Text=These enzymes have various functions in the wound ; they mainly transform dead tissue into liquid , which is either exuded from the wound or consumed by the maggots .
20-1	2172-2177	These	abstract[120]	giv[120]	coref	24-17[160_120]
20-2	2178-2185	enzymes	abstract[120]	giv[120]	_	_
20-3	2186-2190	have	_	_	_	_
20-4	2191-2198	various	abstract[121]	new[121]	ana	20-10[0_121]
20-5	2199-2208	functions	abstract[121]	new[121]	_	_
20-6	2209-2211	in	_	_	_	_
20-7	2212-2215	the	abstract[122]	giv[122]	coref	20-23[126_122]
20-8	2216-2221	wound	abstract[122]	giv[122]	_	_
20-9	2222-2223	;	_	_	_	_
20-10	2224-2228	they	abstract	giv	_	_
20-11	2229-2235	mainly	_	_	_	_
20-12	2236-2245	transform	_	_	_	_
20-13	2246-2250	dead	object[124]	giv[124]	coref	27-8[0_124]
20-14	2251-2257	tissue	object[124]	giv[124]	_	_
20-15	2258-2262	into	_	_	_	_
20-16	2263-2269	liquid	substance[125]	new[125]	_	_
20-17	2270-2271	,	substance[125]	new[125]	_	_
20-18	2272-2277	which	substance[125]	new[125]	_	_
20-19	2278-2280	is	substance[125]	new[125]	_	_
20-20	2281-2287	either	substance[125]	new[125]	_	_
20-21	2288-2294	exuded	substance[125]	new[125]	_	_
20-22	2295-2299	from	substance[125]	new[125]	_	_
20-23	2300-2303	the	substance[125]|abstract[126]	new[125]|giv[126]	coref	23-20[0_126]
20-24	2304-2309	wound	substance[125]|abstract[126]	new[125]|giv[126]	_	_
20-25	2310-2312	or	substance[125]	new[125]	_	_
20-26	2313-2321	consumed	substance[125]	new[125]	_	_
20-27	2322-2324	by	_	_	_	_
20-28	2325-2328	the	animal[127]	giv[127]	_	_
20-29	2329-2336	maggots	animal[127]	giv[127]	_	_
20-30	2337-2338	.	_	_	_	_

#Text=The evacuation of necrosis and reduction in bacterial contamination promotes the regeneration process .
21-1	2339-2342	The	event[128]	new[128]	_	_
21-2	2343-2353	evacuation	event[128]	new[128]	_	_
21-3	2354-2356	of	event[128]	new[128]	_	_
21-4	2357-2365	necrosis	event[128]|abstract	new[128]|giv	coref	26-2
21-5	2366-2369	and	_	_	_	_
21-6	2370-2379	reduction	abstract[130]	new[130]	_	_
21-7	2380-2382	in	abstract[130]	new[130]	_	_
21-8	2383-2392	bacterial	abstract[130]|substance[131]	new[130]|new[131]	_	_
21-9	2393-2406	contamination	abstract[130]|substance[131]	new[130]|new[131]	_	_
21-10	2407-2415	promotes	_	_	_	_
21-11	2416-2419	the	abstract[133]	giv[133]	coref	22-17[139_133]
21-12	2420-2432	regeneration	event|abstract[133]	new|giv[133]	coref	26-31[182_0]
21-13	2433-2440	process	abstract[133]	giv[133]	_	_
21-14	2441-2442	.	_	_	_	_

#Text=The authors of numerous recently published papers have noted chemical substances that influence the promotion of the healing process .
22-1	2443-2446	The	person[134]	new[134]	_	_
22-2	2447-2454	authors	person[134]	new[134]	_	_
22-3	2455-2457	of	person[134]	new[134]	_	_
22-4	2458-2466	numerous	person[134]|abstract[135]	new[134]|new[135]	_	_
22-5	2467-2475	recently	person[134]|abstract[135]	new[134]|new[135]	_	_
22-6	2476-2485	published	person[134]|abstract[135]	new[134]|new[135]	_	_
22-7	2486-2492	papers	person[134]|abstract[135]	new[134]|new[135]	_	_
22-8	2493-2497	have	_	_	_	_
22-9	2498-2503	noted	_	_	_	_
22-10	2504-2512	chemical	substance[136]	new[136]	_	_
22-11	2513-2523	substances	substance[136]	new[136]	_	_
22-12	2524-2528	that	substance[136]	new[136]	_	_
22-13	2529-2538	influence	substance[136]	new[136]	_	_
22-14	2539-2542	the	substance[136]|event[137]	new[136]|new[137]	_	_
22-15	2543-2552	promotion	substance[136]|event[137]	new[136]|new[137]	_	_
22-16	2553-2555	of	substance[136]|event[137]	new[136]|new[137]	_	_
22-17	2556-2559	the	substance[136]|event[137]|abstract[139]	new[136]|new[137]|giv[139]	_	_
22-18	2560-2567	healing	substance[136]|event[137]|object|abstract[139]	new[136]|new[137]|giv|giv[139]	coref	23-32[152_0]
22-19	2568-2575	process	substance[136]|event[137]|abstract[139]	new[136]|new[137]|giv[139]	_	_
22-20	2576-2577	.	_	_	_	_

#Text=The migration of resident epidermal keratinocytes and dermal cells , including fibroblasts and dermal microvascular cells , from the wound margins into the wound bed , is a crucial step in wound healing .
23-1	2578-2581	The	event[140]	new[140]	coref	23-28[150_140]
23-2	2582-2591	migration	event[140]	new[140]	_	_
23-3	2592-2594	of	event[140]	new[140]	_	_
23-4	2595-2603	resident	event[140]|substance[142]	new[140]|new[142]	_	_
23-5	2604-2613	epidermal	event[140]|animal|substance[142]	new[140]|new|new[142]	_	_
23-6	2614-2627	keratinocytes	event[140]|substance[142]	new[140]|new[142]	_	_
23-7	2628-2631	and	event[140]	new[140]	_	_
23-8	2632-2638	dermal	event[140]|object[143]	new[140]|new[143]	coref	23-14[145_143]
23-9	2639-2644	cells	event[140]|object[143]	new[140]|new[143]	_	_
23-10	2645-2646	,	event[140]|object[143]	new[140]|new[143]	_	_
23-11	2647-2656	including	event[140]|object[143]	new[140]|new[143]	_	_
23-12	2657-2668	fibroblasts	event[140]|object[143]|object	new[140]|new[143]|new	_	_
23-13	2669-2672	and	event[140]|object[143]	new[140]|new[143]	_	_
23-14	2673-2679	dermal	event[140]|object[143]|object[145]	new[140]|new[143]|giv[145]	coref	24-36[166_145]
23-15	2680-2693	microvascular	event[140]|object[143]|object[145]	new[140]|new[143]|giv[145]	_	_
23-16	2694-2699	cells	event[140]|object[143]|object[145]	new[140]|new[143]|giv[145]	_	_
23-17	2700-2701	,	event[140]	new[140]	_	_
23-18	2702-2706	from	event[140]	new[140]	_	_
23-19	2707-2710	the	event[140]|place[147]	new[140]|new[147]	_	_
23-20	2711-2716	wound	event[140]|abstract|place[147]	new[140]|giv|new[147]	coref	23-24
23-21	2717-2724	margins	event[140]|place[147]	new[140]|new[147]	_	_
23-22	2725-2729	into	event[140]|place[147]	new[140]|new[147]	_	_
23-23	2730-2733	the	event[140]|place[147]|place[149]	new[140]|new[147]|giv[149]	_	_
23-24	2734-2739	wound	event[140]|place[147]|abstract|place[149]	new[140]|new[147]|giv|giv[149]	coref	23-32
23-25	2740-2743	bed	event[140]|place[147]|place[149]	new[140]|new[147]|giv[149]	_	_
23-26	2744-2745	,	_	_	_	_
23-27	2746-2748	is	_	_	_	_
23-28	2749-2750	a	event[150]	giv[150]	_	_
23-29	2751-2758	crucial	event[150]	giv[150]	_	_
23-30	2759-2763	step	event[150]	giv[150]	_	_
23-31	2764-2766	in	event[150]	giv[150]	_	_
23-32	2767-2772	wound	event[150]|abstract|object[152]	giv[150]|giv|giv[152]	coref|coref	26-11[0_152]|31-4[227_0]
23-33	2773-2780	healing	event[150]|object[152]	giv[150]|giv[152]	_	_
23-34	2781-2782	.	_	_	_	_

#Text=Amino acids , such as L-histidine , 3-guanidinopropionic acid and L-valinol , have been identified in larva secretions , and it has been demonstrated in vitro that these isolated components specifically increase the proliferation of human endothelial cells .
24-1	2783-2788	Amino	object|substance[154]	new|new[154]	_	_
24-2	2789-2794	acids	substance[154]	new[154]	_	_
24-3	2795-2796	,	substance[154]	new[154]	_	_
24-4	2797-2801	such	substance[154]	new[154]	_	_
24-5	2802-2804	as	substance[154]	new[154]	_	_
24-6	2805-2816	L-histidine	substance[154]|substance	new[154]|new	_	_
24-7	2817-2818	,	substance[154]	new[154]	_	_
24-8	2819-2839	3-guanidinopropionic	substance[154]|abstract|substance[157]	new[154]|new|new[157]	_	_
24-9	2840-2844	acid	substance[154]|substance[157]	new[154]|new[157]	_	_
24-10	2845-2848	and	substance[154]	new[154]	_	_
24-11	2849-2858	L-valinol	substance[154]|substance	new[154]|new	ana	24-21
24-12	2859-2860	,	_	_	_	_
24-13	2861-2865	have	_	_	_	_
24-14	2866-2870	been	_	_	_	_
24-15	2871-2881	identified	_	_	_	_
24-16	2882-2884	in	_	_	_	_
24-17	2885-2890	larva	animal|abstract[160]	new|giv[160]	coref	25-19[172_160]
24-18	2891-2901	secretions	abstract[160]	giv[160]	_	_
24-19	2902-2903	,	_	_	_	_
24-20	2904-2907	and	_	_	_	_
24-21	2908-2910	it	substance	giv	_	_
24-22	2911-2914	has	_	_	_	_
24-23	2915-2919	been	_	_	_	_
24-24	2920-2932	demonstrated	_	_	_	_
24-25	2933-2935	in	_	_	_	_
24-26	2936-2941	vitro	organization	new	_	_
24-27	2942-2946	that	_	_	_	_
24-28	2947-2952	these	substance[163]	new[163]	coref	25-13[171_163]
24-29	2953-2961	isolated	substance[163]	new[163]	_	_
24-30	2962-2972	components	substance[163]	new[163]	_	_
24-31	2973-2985	specifically	_	_	_	_
24-32	2986-2994	increase	_	_	_	_
24-33	2995-2998	the	abstract[164]	new[164]	_	_
24-34	2999-3012	proliferation	abstract[164]	new[164]	_	_
24-35	3013-3015	of	abstract[164]	new[164]	_	_
24-36	3016-3021	human	abstract[164]|object[166]	new[164]|giv[166]	_	_
24-37	3022-3033	endothelial	abstract[164]|animal|object[166]	new[164]|new|giv[166]	_	_
24-38	3034-3039	cells	abstract[164]|object[166]	new[164]|giv[166]	_	_
24-39	3040-3041	.	_	_	_	_

#Text=Collagenase speeds up the process of proteolysis by decomposing the material into smaller components , digested later by other enzymes secreted by the larvae .
25-1	3042-3053	Collagenase	substance	giv	_	_
25-2	3054-3060	speeds	_	_	_	_
25-3	3061-3063	up	_	_	_	_
25-4	3064-3067	the	event[168]	new[168]	_	_
25-5	3068-3075	process	event[168]	new[168]	_	_
25-6	3076-3078	of	event[168]	new[168]	_	_
25-7	3079-3090	proteolysis	event[168]|abstract	new[168]|new	_	_
25-8	3091-3093	by	_	_	_	_
25-9	3094-3105	decomposing	_	_	_	_
25-10	3106-3109	the	substance[170]	new[170]	_	_
25-11	3110-3118	material	substance[170]	new[170]	_	_
25-12	3119-3123	into	_	_	_	_
25-13	3124-3131	smaller	substance[171]	giv[171]	_	_
25-14	3132-3142	components	substance[171]	giv[171]	_	_
25-15	3143-3144	,	_	_	_	_
25-16	3145-3153	digested	_	_	_	_
25-17	3154-3159	later	_	_	_	_
25-18	3160-3162	by	_	_	_	_
25-19	3163-3168	other	abstract[172]	giv[172]	coref	33-12[237_172]
25-20	3169-3176	enzymes	abstract[172]	giv[172]	_	_
25-21	3177-3185	secreted	abstract[172]	giv[172]	_	_
25-22	3186-3188	by	abstract[172]	giv[172]	_	_
25-23	3189-3192	the	abstract[172]|plant[173]	giv[172]|giv[173]	coref	28-9[0_173]
25-24	3193-3199	larvae	abstract[172]|plant[173]	giv[172]|giv[173]	_	_
25-25	3200-3201	.	_	_	_	_

#Text=Once necrosis is effectively removed , the consecutive stages of healing are facilitated by the increased phagocytic activity of leukocytes and higher oxygen pressure , resulting in optimum conditions for the regeneration of damaged tissues .
26-1	3202-3206	Once	_	_	_	_
26-2	3207-3215	necrosis	abstract	giv	_	_
26-3	3216-3218	is	_	_	_	_
26-4	3219-3230	effectively	_	_	_	_
26-5	3231-3238	removed	_	_	_	_
26-6	3239-3240	,	_	_	_	_
26-7	3241-3244	the	abstract[175]	new[175]	_	_
26-8	3245-3256	consecutive	abstract[175]	new[175]	_	_
26-9	3257-3263	stages	abstract[175]	new[175]	_	_
26-10	3264-3266	of	abstract[175]	new[175]	_	_
26-11	3267-3274	healing	abstract[175]|object	new[175]|giv	_	_
26-12	3275-3278	are	_	_	_	_
26-13	3279-3290	facilitated	_	_	_	_
26-14	3291-3293	by	_	_	_	_
26-15	3294-3297	the	abstract[177]	new[177]	_	_
26-16	3298-3307	increased	abstract[177]	new[177]	_	_
26-17	3308-3318	phagocytic	abstract[177]	new[177]	_	_
26-18	3319-3327	activity	abstract[177]	new[177]	_	_
26-19	3328-3330	of	abstract[177]	new[177]	_	_
26-20	3331-3341	leukocytes	abstract[177]|substance	new[177]|new	_	_
26-21	3342-3345	and	_	_	_	_
26-22	3346-3352	higher	abstract[180]	new[180]	_	_
26-23	3353-3359	oxygen	substance|abstract[180]	new|new[180]	_	_
26-24	3360-3368	pressure	abstract[180]	new[180]	_	_
26-25	3369-3370	,	_	_	_	_
26-26	3371-3380	resulting	_	_	_	_
26-27	3381-3383	in	_	_	_	_
26-28	3384-3391	optimum	abstract[181]	new[181]	_	_
26-29	3392-3402	conditions	abstract[181]	new[181]	_	_
26-30	3403-3406	for	abstract[181]	new[181]	_	_
26-31	3407-3410	the	abstract[181]|event[182]	new[181]|giv[182]	_	_
26-32	3411-3423	regeneration	abstract[181]|event[182]	new[181]|giv[182]	_	_
26-33	3424-3426	of	abstract[181]|event[182]	new[181]|giv[182]	_	_
26-34	3427-3434	damaged	abstract[181]|event[182]|object[183]	new[181]|giv[182]|new[183]	_	_
26-35	3435-3442	tissues	abstract[181]|event[182]|object[183]	new[181]|giv[182]|new[183]	_	_
26-36	3443-3444	.	_	_	_	_

#Text=Proteolytic digestion is the initial act of tissue repair , leading to hemostasis , thrombosis , inflammatory cell activation and the reconstruction of tissue .
27-1	3445-3456	Proteolytic	event[184]	giv[184]	coref	27-4[185_184]
27-2	3457-3466	digestion	event[184]	giv[184]	_	_
27-3	3467-3469	is	_	_	_	_
27-4	3470-3473	the	event[185]	giv[185]	_	_
27-5	3474-3481	initial	event[185]	giv[185]	_	_
27-6	3482-3485	act	event[185]	giv[185]	_	_
27-7	3486-3488	of	event[185]	giv[185]	_	_
27-8	3489-3495	tissue	event[185]|object|event[187]	giv[185]|giv|new[187]	coref	27-24
27-9	3496-3502	repair	event[185]|event[187]	giv[185]|new[187]	_	_
27-10	3503-3504	,	event[185]	giv[185]	_	_
27-11	3505-3512	leading	event[185]	giv[185]	_	_
27-12	3513-3515	to	event[185]	giv[185]	_	_
27-13	3516-3526	hemostasis	event[185]|abstract	giv[185]|new	_	_
27-14	3527-3528	,	event[185]	giv[185]	_	_
27-15	3529-3539	thrombosis	event[185]|abstract	giv[185]|new	_	_
27-16	3540-3541	,	event[185]	giv[185]	_	_
27-17	3542-3554	inflammatory	event[185]|place[190]|event[191]	giv[185]|new[190]|new[191]	_	_
27-18	3555-3559	cell	event[185]|place[190]|event[191]	giv[185]|new[190]|new[191]	_	_
27-19	3560-3570	activation	event[185]|event[191]	giv[185]|new[191]	_	_
27-20	3571-3574	and	event[185]	giv[185]	_	_
27-21	3575-3578	the	event[185]|event[192]	giv[185]|new[192]	_	_
27-22	3579-3593	reconstruction	event[185]|event[192]	giv[185]|new[192]	_	_
27-23	3594-3596	of	event[185]|event[192]	giv[185]|new[192]	_	_
27-24	3597-3603	tissue	event[185]|event[192]|object	giv[185]|new[192]|giv	coref	33-1[235_0]
27-25	3604-3605	.	_	_	_	_

#Text=Several studies suggest that the beneficial effect of larvae may be due to their ability to reduce pro-inflammatory factors .
28-1	3606-3613	Several	abstract[194]	new[194]	_	_
28-2	3614-3621	studies	abstract[194]	new[194]	_	_
28-3	3622-3629	suggest	_	_	_	_
28-4	3630-3634	that	_	_	_	_
28-5	3635-3638	the	abstract[195]	new[195]	_	_
28-6	3639-3649	beneficial	abstract[195]	new[195]	_	_
28-7	3650-3656	effect	abstract[195]	new[195]	_	_
28-8	3657-3659	of	abstract[195]	new[195]	_	_
28-9	3660-3666	larvae	abstract[195]|plant	new[195]|giv	ana	28-14
28-10	3667-3670	may	_	_	_	_
28-11	3671-3673	be	_	_	_	_
28-12	3674-3677	due	_	_	_	_
28-13	3678-3680	to	_	_	_	_
28-14	3681-3686	their	plant|abstract[198]	giv|new[198]	_	_
28-15	3687-3694	ability	abstract[198]	new[198]	_	_
28-16	3695-3697	to	abstract[198]	new[198]	_	_
28-17	3698-3704	reduce	abstract[198]	new[198]	_	_
28-18	3705-3721	pro-inflammatory	abstract[198]|abstract[199]	new[198]|new[199]	coref	34-7[242_199]
28-19	3722-3729	factors	abstract[198]|abstract[199]	new[198]|new[199]	_	_
28-20	3730-3731	.	_	_	_	_

#Text=The work of Pecivova et al. studied the effect of the Lucilia sericata salivary gland extract on opsonized neutrophils , stimulated with zymogen and unstimulated neutrophils .
29-1	3732-3735	The	abstract[200]	new[200]	_	_
29-2	3736-3740	work	abstract[200]	new[200]	_	_
29-3	3741-3743	of	abstract[200]	new[200]	_	_
29-4	3744-3752	Pecivova	abstract[200]|person	new[200]|new	_	_
29-5	3753-3755	et	abstract[200]	new[200]	_	_
29-6	3756-3759	al.	abstract[200]	new[200]	_	_
29-7	3760-3767	studied	_	_	_	_
29-8	3768-3771	the	abstract[202]	new[202]	coref	30-5[212_202]
29-9	3772-3778	effect	abstract[202]	new[202]	_	_
29-10	3779-3781	of	abstract[202]	new[202]	_	_
29-11	3782-3785	the	abstract[202]|substance[206]	new[202]|new[206]	coref	30-1[211_206]
29-12	3786-3793	Lucilia	abstract[202]|place|abstract[204]|substance[206]	new[202]|giv|new[204]|new[206]	_	_
29-13	3794-3802	sericata	abstract[202]|abstract[204]|substance[206]	new[202]|new[204]|new[206]	_	_
29-14	3803-3811	salivary	abstract[202]|substance[205]|substance[206]	new[202]|new[205]|new[206]	coref	30-1[210_205]
29-15	3812-3817	gland	abstract[202]|substance[205]|substance[206]	new[202]|new[205]|new[206]	_	_
29-16	3818-3825	extract	abstract[202]|substance[206]	new[202]|new[206]	_	_
29-17	3826-3828	on	abstract[202]	new[202]	_	_
29-18	3829-3838	opsonized	abstract[202]|abstract[207]	new[202]|new[207]	coref	29-25[209_207]
29-19	3839-3850	neutrophils	abstract[202]|abstract[207]	new[202]|new[207]	_	_
29-20	3851-3852	,	abstract[202]|abstract[207]	new[202]|new[207]	_	_
29-21	3853-3863	stimulated	abstract[202]|abstract[207]	new[202]|new[207]	_	_
29-22	3864-3868	with	abstract[202]|abstract[207]	new[202]|new[207]	_	_
29-23	3869-3876	zymogen	abstract[202]|abstract[207]|substance	new[202]|new[207]|new	_	_
29-24	3877-3880	and	abstract[202]|abstract[207]	new[202]|new[207]	_	_
29-25	3881-3893	unstimulated	abstract[202]|abstract[207]|abstract[209]	new[202]|new[207]|giv[209]	coref	30-14[218_209]
29-26	3894-3905	neutrophils	abstract[202]|abstract[207]|abstract[209]	new[202]|new[207]|giv[209]	_	_
29-27	3906-3907	.	_	_	_	_

#Text=Salivary gland extract had no effect on superoxide production and myeloperoxidase release from unstimulated neutrophils , but significantly reduced both peroxide production and MPO secretion levels in zsonogen-stimulated opsonized neutrophils .
30-1	3908-3916	Salivary	substance[210]|substance[211]	giv[210]|giv[211]	_	_
30-2	3917-3922	gland	substance[210]|substance[211]	giv[210]|giv[211]	_	_
30-3	3923-3930	extract	substance[211]	giv[211]	_	_
30-4	3931-3934	had	_	_	_	_
30-5	3935-3937	no	abstract[212]	giv[212]	_	_
30-6	3938-3944	effect	abstract[212]	giv[212]	_	_
30-7	3945-3947	on	abstract[212]	giv[212]	_	_
30-8	3948-3958	superoxide	abstract[212]|substance|abstract[214]|abstract[215]	giv[212]|new|new[214]|new[215]	coref|coref	30-20[220_214]|30-20[221_215]
30-9	3959-3969	production	abstract[212]|abstract[214]|abstract[215]	giv[212]|new[214]|new[215]	_	_
30-10	3970-3973	and	abstract[212]|abstract[215]	giv[212]|new[215]	_	_
30-11	3974-3989	myeloperoxidase	abstract[212]|abstract[215]|abstract|event[217]	giv[212]|new[215]|new|new[217]	_	_
30-12	3990-3997	release	abstract[212]|abstract[215]|event[217]	giv[212]|new[215]|new[217]	_	_
30-13	3998-4002	from	abstract[212]|abstract[215]|event[217]	giv[212]|new[215]|new[217]	_	_
30-14	4003-4015	unstimulated	abstract[212]|abstract[215]|event[217]|abstract[218]	giv[212]|new[215]|new[217]|giv[218]	coref	30-28[225_218]
30-15	4016-4027	neutrophils	abstract[212]|abstract[215]|event[217]|abstract[218]	giv[212]|new[215]|new[217]|giv[218]	_	_
30-16	4028-4029	,	_	_	_	_
30-17	4030-4033	but	_	_	_	_
30-18	4034-4047	significantly	_	_	_	_
30-19	4048-4055	reduced	_	_	_	_
30-20	4056-4060	both	abstract[220]|abstract[221]	giv[220]|giv[221]	_	_
30-21	4061-4069	peroxide	substance|abstract[220]|abstract[221]	new|giv[220]|giv[221]	_	_
30-22	4070-4080	production	abstract[220]|abstract[221]	giv[220]|giv[221]	_	_
30-23	4081-4084	and	abstract[221]	giv[221]	_	_
30-24	4085-4088	MPO	abstract[221]|substance|abstract[224]	giv[221]|new|new[224]	_	_
30-25	4089-4098	secretion	abstract[221]|abstract|abstract[224]	giv[221]|new|new[224]	_	_
30-26	4099-4105	levels	abstract[221]|abstract[224]	giv[221]|new[224]	_	_
30-27	4106-4108	in	abstract[221]|abstract[224]	giv[221]|new[224]	_	_
30-28	4109-4128	zsonogen-stimulated	abstract[221]|abstract[224]|abstract[225]	giv[221]|new[224]|giv[225]	_	_
30-29	4129-4138	opsonized	abstract[221]|abstract[224]|abstract[225]	giv[221]|new[224]|giv[225]	_	_
30-30	4139-4150	neutrophils	abstract[221]|abstract[224]|abstract[225]	giv[221]|new[224]|giv[225]	_	_
30-31	4151-4152	.	_	_	_	_

#Text=Following debridement , the wound may be appropriately assessed .
31-1	4153-4162	Following	_	_	_	_
31-2	4163-4174	debridement	event	giv	ana	32-3
31-3	4175-4176	,	_	_	_	_
31-4	4177-4180	the	abstract[227]	giv[227]	coref	32-13[0_227]
31-5	4181-4186	wound	abstract[227]	giv[227]	_	_
31-6	4187-4190	may	_	_	_	_
31-7	4191-4193	be	_	_	_	_
31-8	4194-4207	appropriately	_	_	_	_
31-9	4208-4216	assessed	_	_	_	_
31-10	4217-4218	.	_	_	_	_

#Text=Consequently , it is also possible to introduce other methods that promote wound closure , or to perform a skin transplant .
32-1	4219-4231	Consequently	_	_	_	_
32-2	4232-4233	,	_	_	_	_
32-3	4234-4236	it	event	giv	_	_
32-4	4237-4239	is	_	_	_	_
32-5	4240-4244	also	_	_	_	_
32-6	4245-4253	possible	_	_	_	_
32-7	4254-4256	to	_	_	_	_
32-8	4257-4266	introduce	_	_	_	_
32-9	4267-4272	other	abstract[229]	new[229]	_	_
32-10	4273-4280	methods	abstract[229]	new[229]	_	_
32-11	4281-4285	that	abstract[229]	new[229]	_	_
32-12	4286-4293	promote	abstract[229]	new[229]	_	_
32-13	4294-4299	wound	abstract[229]|abstract|event[231]	new[229]|giv|new[231]	coref	33-5[236_0]
32-14	4300-4307	closure	abstract[229]|event[231]	new[229]|new[231]	_	_
32-15	4308-4309	,	abstract[229]	new[229]	_	_
32-16	4310-4312	or	abstract[229]	new[229]	_	_
32-17	4313-4315	to	abstract[229]	new[229]	_	_
32-18	4316-4323	perform	abstract[229]	new[229]	_	_
32-19	4324-4325	a	abstract[229]|event[233]	new[229]|new[233]	_	_
32-20	4326-4330	skin	abstract[229]|object|event[233]	new[229]|new|new[233]	_	_
32-21	4331-4341	transplant	abstract[229]|event[233]	new[229]|new[233]	_	_
32-22	4342-4343	.	_	_	_	_

#Text=The granulation tissue in the wound , debrided and stimulated by larval secretions , should be dressed as soon as possible with the chosen method of local treatment .
33-1	4344-4347	The	object[235]	giv[235]	coref	34-14[0_235]
33-2	4348-4359	granulation	abstract|object[235]	new|giv[235]	_	_
33-3	4360-4366	tissue	object[235]	giv[235]	_	_
33-4	4367-4369	in	object[235]	giv[235]	_	_
33-5	4370-4373	the	object[235]|abstract[236]	giv[235]|giv[236]	coref	34-19[0_236]
33-6	4374-4379	wound	object[235]|abstract[236]	giv[235]|giv[236]	_	_
33-7	4380-4381	,	object[235]	giv[235]	_	_
33-8	4382-4390	debrided	object[235]	giv[235]	_	_
33-9	4391-4394	and	object[235]	giv[235]	_	_
33-10	4395-4405	stimulated	object[235]	giv[235]	_	_
33-11	4406-4408	by	_	_	_	_
33-12	4409-4415	larval	abstract[237]	giv[237]	_	_
33-13	4416-4426	secretions	abstract[237]	giv[237]	_	_
33-14	4427-4428	,	_	_	_	_
33-15	4429-4435	should	_	_	_	_
33-16	4436-4438	be	_	_	_	_
33-17	4439-4446	dressed	_	_	_	_
33-18	4447-4449	as	_	_	_	_
33-19	4450-4454	soon	_	_	_	_
33-20	4455-4457	as	_	_	_	_
33-21	4458-4466	possible	_	_	_	_
33-22	4467-4471	with	_	_	_	_
33-23	4472-4475	the	abstract[238]	new[238]	coref	34-4[0_238]
33-24	4476-4482	chosen	abstract[238]	new[238]	_	_
33-25	4483-4489	method	abstract[238]	new[238]	_	_
33-26	4490-4492	of	abstract[238]	new[238]	_	_
33-27	4493-4498	local	abstract[238]|event[239]	new[238]|new[239]	_	_
33-28	4499-4508	treatment	abstract[238]|event[239]	new[238]|new[239]	_	_
33-29	4509-4510	.	_	_	_	_

#Text=The choice of method depends on several factors , such as level of tissue destruction , area , wound etiopathogenesis , and general condition of the patient .
34-1	4511-4514	The	abstract[240]	new[240]	_	_
34-2	4515-4521	choice	abstract[240]	new[240]	_	_
34-3	4522-4524	of	abstract[240]	new[240]	_	_
34-4	4525-4531	method	abstract[240]|abstract	new[240]|giv	_	_
34-5	4532-4539	depends	_	_	_	_
34-6	4540-4542	on	_	_	_	_
34-7	4543-4550	several	abstract[242]	giv[242]	_	_
34-8	4551-4558	factors	abstract[242]	giv[242]	_	_
34-9	4559-4560	,	abstract[242]	giv[242]	_	_
34-10	4561-4565	such	abstract[242]	giv[242]	_	_
34-11	4566-4568	as	abstract[242]	giv[242]	_	_
34-12	4569-4574	level	abstract[242]|abstract[243]	giv[242]|new[243]	_	_
34-13	4575-4577	of	abstract[242]|abstract[243]	giv[242]|new[243]	_	_
34-14	4578-4584	tissue	abstract[242]|abstract[243]|object|event[245]	giv[242]|new[243]|giv|new[245]	coref	37-17[272_0]
34-15	4585-4596	destruction	abstract[242]|abstract[243]|event[245]	giv[242]|new[243]|new[245]	_	_
34-16	4597-4598	,	abstract[242]|abstract[243]	giv[242]|new[243]	_	_
34-17	4599-4603	area	abstract[242]|abstract[243]|abstract	giv[242]|new[243]|new	_	_
34-18	4604-4605	,	abstract[242]|abstract[243]	giv[242]|new[243]	_	_
34-19	4606-4611	wound	abstract[242]|abstract[243]|abstract|abstract[248]	giv[242]|new[243]|giv|new[248]	coref	36-6
34-20	4612-4628	etiopathogenesis	abstract[242]|abstract[243]|abstract[248]	giv[242]|new[243]|new[248]	_	_
34-21	4629-4630	,	abstract[242]|abstract[243]	giv[242]|new[243]	_	_
34-22	4631-4634	and	abstract[242]|abstract[243]	giv[242]|new[243]	_	_
34-23	4635-4642	general	abstract[242]|abstract[243]|abstract[249]	giv[242]|new[243]|new[249]	coref	37-27[275_249]
34-24	4643-4652	condition	abstract[242]|abstract[243]|abstract[249]	giv[242]|new[243]|new[249]	_	_
34-25	4653-4655	of	abstract[242]|abstract[243]|abstract[249]	giv[242]|new[243]|new[249]	_	_
34-26	4656-4659	the	abstract[242]|abstract[243]|abstract[249]|person[250]	giv[242]|new[243]|new[249]|new[250]	coref	37-28[274_250]
34-27	4660-4667	patient	abstract[242]|abstract[243]|abstract[249]|person[250]	giv[242]|new[243]|new[249]|new[250]	_	_
34-28	4668-4669	.	_	_	_	_

#Text=Wound management criteria should be carefully implemented based on the TIME concept .
35-1	4670-4675	Wound	person|abstract[252]|abstract[253]	new|new[252]|new[253]	_	_
35-2	4676-4686	management	abstract[252]|abstract[253]	new[252]|new[253]	_	_
35-3	4687-4695	criteria	abstract[253]	new[253]	_	_
35-4	4696-4702	should	_	_	_	_
35-5	4703-4705	be	_	_	_	_
35-6	4706-4715	carefully	_	_	_	_
35-7	4716-4727	implemented	_	_	_	_
35-8	4728-4733	based	_	_	_	_
35-9	4734-4736	on	_	_	_	_
35-10	4737-4740	the	abstract[255]	new[255]	_	_
35-11	4741-4745	TIME	abstract|abstract[255]	new|new[255]	_	_
35-12	4746-4753	concept	abstract[255]	new[255]	_	_
35-13	4754-4755	.	_	_	_	_

#Text=The use of negative pressure wound therapy ( NPWT ) is effective in shrinking the wound , reducing exudate and bacteria , and stimulating neoangigenesis , specialized dressings , in the case of superficial and penetrative lesions that do not qualify for surgery .
36-1	4756-4759	The	event[256]	new[256]	_	_
36-2	4760-4763	use	event[256]	new[256]	_	_
36-3	4764-4766	of	event[256]	new[256]	_	_
36-4	4767-4775	negative	event[256]|event[258]	new[256]|giv[258]	_	_
36-5	4776-4784	pressure	event[256]|event[258]	new[256]|giv[258]	_	_
36-6	4785-4790	wound	event[256]|abstract|event[258]	new[256]|giv|giv[258]	coref	36-15[260_0]
36-7	4791-4798	therapy	event[256]|event[258]	new[256]|giv[258]	_	_
36-8	4799-4800	(	_	_	_	_
36-9	4801-4805	NPWT	abstract	new	_	_
36-10	4806-4807	)	_	_	_	_
36-11	4808-4810	is	_	_	_	_
36-12	4811-4820	effective	_	_	_	_
36-13	4821-4823	in	_	_	_	_
36-14	4824-4833	shrinking	_	_	_	_
36-15	4834-4837	the	abstract[260]	giv[260]	_	_
36-16	4838-4843	wound	abstract[260]	giv[260]	_	_
36-17	4844-4845	,	_	_	_	_
36-18	4846-4854	reducing	_	_	_	_
36-19	4855-4862	exudate	substance|substance[262]	giv|giv[262]	_	_
36-20	4863-4866	and	substance[262]	giv[262]	_	_
36-21	4867-4875	bacteria	substance[262]|substance	giv[262]|new	_	_
36-22	4876-4877	,	_	_	_	_
36-23	4878-4881	and	_	_	_	_
36-24	4882-4893	stimulating	_	_	_	_
36-25	4894-4908	neoangigenesis	object	new	appos	36-27[265_0]
36-26	4909-4910	,	_	_	_	_
36-27	4911-4922	specialized	object[265]	giv[265]	coref	37-23[0_265]
36-28	4923-4932	dressings	object[265]	giv[265]	_	_
36-29	4933-4934	,	_	_	_	_
36-30	4935-4937	in	_	_	_	_
36-31	4938-4941	the	abstract[266]	new[266]	_	_
36-32	4942-4946	case	abstract[266]	new[266]	_	_
36-33	4947-4949	of	abstract[266]	new[266]	_	_
36-34	4950-4961	superficial	abstract[266]|object[267]	new[266]|new[267]	_	_
36-35	4962-4965	and	abstract[266]|object[267]	new[266]|new[267]	_	_
36-36	4966-4977	penetrative	abstract[266]|object[267]	new[266]|new[267]	_	_
36-37	4978-4985	lesions	abstract[266]|object[267]	new[266]|new[267]	_	_
36-38	4986-4990	that	abstract[266]|object[267]	new[266]|new[267]	_	_
36-39	4991-4993	do	abstract[266]|object[267]	new[266]|new[267]	_	_
36-40	4994-4997	not	abstract[266]|object[267]	new[266]|new[267]	_	_
36-41	4998-5005	qualify	abstract[266]|object[267]	new[266]|new[267]	_	_
36-42	5006-5009	for	abstract[266]|object[267]	new[266]|new[267]	_	_
36-43	5010-5017	surgery	abstract[266]|object[267]|event	new[266]|new[267]|new	_	_
36-44	5018-5019	.	_	_	_	_

#Text=There are clinical situations , especially in terminally ill patients , in which wounds debrided from necrotic tissue are only managed with dressings , due to the patient ’s condition and poor prognosis .
37-1	5020-5025	There	_	_	_	_
37-2	5026-5029	are	_	_	_	_
37-3	5030-5038	clinical	abstract[269]	new[269]	_	_
37-4	5039-5049	situations	abstract[269]	new[269]	_	_
37-5	5050-5051	,	abstract[269]	new[269]	_	_
37-6	5052-5062	especially	abstract[269]|person[270]	new[269]|new[270]	_	_
37-7	5063-5065	in	abstract[269]|person[270]	new[269]|new[270]	_	_
37-8	5066-5076	terminally	abstract[269]|person[270]	new[269]|new[270]	_	_
37-9	5077-5080	ill	abstract[269]|person[270]	new[269]|new[270]	_	_
37-10	5081-5089	patients	abstract[269]|person[270]	new[269]|new[270]	_	_
37-11	5090-5091	,	abstract[269]	new[269]	_	_
37-12	5092-5094	in	abstract[269]	new[269]	_	_
37-13	5095-5100	which	abstract[269]	new[269]	_	_
37-14	5101-5107	wounds	abstract[269]|object[271]	new[269]|new[271]	_	_
37-15	5108-5116	debrided	abstract[269]|object[271]	new[269]|new[271]	_	_
37-16	5117-5121	from	abstract[269]|object[271]	new[269]|new[271]	_	_
37-17	5122-5130	necrotic	abstract[269]|object[271]|object[272]	new[269]|new[271]|giv[272]	_	_
37-18	5131-5137	tissue	abstract[269]|object[271]|object[272]	new[269]|new[271]|giv[272]	_	_
37-19	5138-5141	are	abstract[269]	new[269]	_	_
37-20	5142-5146	only	abstract[269]	new[269]	_	_
37-21	5147-5154	managed	abstract[269]	new[269]	_	_
37-22	5155-5159	with	abstract[269]	new[269]	_	_
37-23	5160-5169	dressings	abstract[269]|object	new[269]|giv	_	_
37-24	5170-5171	,	abstract[269]	new[269]	_	_
37-25	5172-5175	due	abstract[269]	new[269]	_	_
37-26	5176-5178	to	abstract[269]	new[269]	_	_
37-27	5179-5182	the	abstract[269]|abstract[275]	new[269]|giv[275]	_	_
37-28	5183-5190	patient	abstract[269]|person[274]|abstract[275]	new[269]|giv[274]|giv[275]	_	_
37-29	5191-5193	’s	abstract[269]|person[274]|abstract[275]	new[269]|giv[274]|giv[275]	_	_
37-30	5194-5203	condition	abstract[269]|abstract[275]	new[269]|giv[275]	_	_
37-31	5204-5207	and	abstract[269]	new[269]	_	_
37-32	5208-5212	poor	abstract[269]|abstract[276]	new[269]|new[276]	_	_
37-33	5213-5222	prognosis	abstract[269]|abstract[276]	new[269]|new[276]	_	_
37-34	5223-5224	.	_	_	_	_
